Last reviewed · How we verify

NCT00756795: I-PAP

Increasing Physical Activity of Patients With Head and Neck Cancer (I-PAP Study)

Withdrawn NA Last updated 23 September 2024
What this trial tests

NA trial testing Intervention group in Head and Neck Cancer. Withdrawn.

Timeline
24 April 2008
Primary endpoint
5 August 2010
5 August 2010

Quick facts

Lead sponsorUniversity of Nebraska
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Start date24 April 2008
Primary completion5 August 2010
Estimated completion5 August 2010

Drugs / interventions tested

Conditions studied

Sponsor

University of Nebraska

Who can join

19 and older, any sex, with Head and Neck Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Generally, patients who have undergone treatments for Head Neck Cancer have a decreased quality of life and experience depression and fatigue. Regular physical activity improves emotional well-being, increases immunological response, improves wound healing, lessens fatigue and improves general functionality and quality of life. This study will determine effectiveness of the 12-week exercise intervention program, determine if physically active patients differ in quality of life, depression and fatigue during the course of the study, and determine if the change in physical activity levels is related to changes in immune responses.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Objective monitoring of physical activity after a cancer diagnosis: challenges and opportunities for enhancing cancer control.
    Rogers LQ. · · 2010 · cited 13× · PMID 21603254 · DOI 10.1179/174328810x12814016178872

Verify or expand the search:

Other trials of Intervention group

Trials testing the same drug.

Other recruiting trials for Head and Neck Cancer

Currently open trials in the same condition.

Other University of Nebraska trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00756795.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing